Please login to the form below
Lexicon
This page shows the latest Lexicon news and features for those working in and with pharma, biotech and healthcare.
FDA advisors say no to empagliflozin in type 1 diabetes
Earlier this year the panel was split on whether they should back approval of Lexicon Pharma’s Zynquista (sotagliflozin) as an insulin adjunct in these patients, and the FDA’s subsequent ... rejection of the indication prompted Sanofi to exit its
Latest news
-
Sanofi exits Zynquista alliance with Lexicon
Sanofi/Lexicon had hoped that the dual targeting may provide added glucose control with fewer side effects relative to selective SGLT2 inhibitors. ... for demonstrating cardiovascular and renal benefits,” said Lexicon’s chief executive officer Lonnel
-
Sanofi sheds jobs in R&D restructuring
The FDA also recently rejected its Lexicon partnered SGLT1/SGLT2 inhibitor Zynquista.
-
J&J’s Invokana first SGLT2 to show kidney disease benefits
Meanwhile Sanofi and Lexicon's Zynquista and Eli Lilly and Boehringer Ingeheim's market leader Jardiance are also both in renal outcomes trials, with their respective results expected by 2022.
-
Success for AZ, setback for Sanofi in type 1 diabetes
Sanofi has been less fortunate with its US marketing application for Lexicon Pharma-partnered dual SGLT1/SGLT2 inhibitor Zynquista (sotagliflozin) alongside insulin in type 1 diabetes, however, as this was rejected ... Both AZ and Sanofi/Lexicon’s
-
CHMP backs Lynparza in breast cancer, Dupixent in asthma
There was also another positive opinion for Sanofi, this time for its Lexicon Pharma-partnered SGLT1/2 inhibitor Zynquista (sotagliflozin) as an oral add-on to insulin therapy to improve blood
More from news
Approximately 3 fully matching, plus 14 partially matching documents found.
Latest Intelligence
-
Breaking from tradition - social media at medical congresses
Taking the opportunity to listen will also give you a sense of the tone of the online conversation, and very practically, the language, lexicon and hashtags that HCPs are using to
-
What pharma marketers can learn from Disney
We need to make it easy for audiences to consume our content using language and lexicon they are familiar with, and provide information in short relevant bites that is actionable in
-
It’s not the end of the world, is it?
True and transparent value. The phrase ‘value-based healthcare’ entered the industry’s lexicon some years ago and there isn’t a pharmaceutical or medical technology company in existence that does
-
The first, my last, my everything
Because if the modern-day lexicon is anything to go by, the patient has become The First, the Last, the Everything for the global industry.
-
Communication is the key to unlocking the potential of immuno-oncology
Marje Isabelle, Founder and CEO, Fertile Matters. This means working with others to define a new lexicon for cancer care; helping healthcare professionals stay on top of the deluge of new
More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest appointments
-
Weekly comms appointments
In this newly created position, Pyati will develop a science-driven strategy, implement situational assessments and workshops and develop scientific platforms and lexicons.
-
Linda Law joins Advicenne as US VP, clinical development and med affairs
Law’s career has seen her serve in various positions for pharmaceutical companies including Procter &Gamble, Lexicon Pharmaceuticals and she has consulted on evaluation and development projects with Takeda, Confluence and
-
Onconova appoints Ajay Bansal as chief financial officer
Bansal (pictured) served as chief financial officer at Complete Genomics since May 2010, having previously held the role of chief financial officer and executive VP of business development at Lexicon Therapeutics. ... In addition to his prior roles at
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Mastering the precision medicine opportunity
While some might say that this change in lexicon is merely a progression in language, I would argue there are differences in the two approaches to identifying and treating patients.
-
Social Media and Health: the Cure or the Disease?
He is also changing the Facebook lexicon, swapping 'community' for 'connection' as the ultimate good. . .
-
The science of experience planning in pharma media
Experience planning is a popular phrase in today’s marketing lexicon. It focuses on how each interaction with a (potential) customer is an ‘experience’ and how to best plan this in
-
The Seven Cs Of Cross-Functional Brand Planning
Thinking about the plan, the process, how we go about it, the tools and lexicon. This is as much about language and definitions as it is about planning steps, stages, philosophy
-
Framing, provocation, and truth
It seems to be a word creeping steadily into the promotional lexicon of marketing research.
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Featured jobs
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
-
Senior Medical Writer
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
-
Account Director
-
Salary TBC
-
Account Executive
-
Salary TBC
-
Account Supervisor
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
Subscribe to our email news alerts
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- Nucala works in rare inflammatory disease, says GSK
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- Otsuka presses on with Alzheimer’s agitation drug
- Four Ms
- Using human insights to push healthcare communications forward
- RWE Blog 4: The place of real-world evidence in the market access strategy
- Don’t we all need to be able to change something?
- Antibiotic resistance: The silent pandemic
- BMS, Celgene merger should close this week after FTC okay
- The NHS is facing shortages of lifesaving treatments, says internal document
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- Using human insights to push healthcare communications forward
- This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
- RWE Blog 4: The place of real-world evidence in the market access strategy
- The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
- RWE Blog 3: Is real-world evidence the holy grail
- We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
Quick links
Infographics
